Ozuah Philip 4

What Happened
Philip Ozuah, a director of Cigna Group (CI), acquired 782 shares via a grant/award on April 22, 2026. The Form 4 reports the acquisition price as $0.00 per share (total $0.00), indicating a compensatory award rather than an open-market purchase. This was an acquisition (award), not a sale.

Key Details

• Transaction date: 2026-04-22; Form 4 filed: 2026-04-24 (appears timely within the typical 2-business-day window)
• Transaction type/code: Award/Grant (A); 782 shares acquired at $0.00 per share
• Shares owned after transaction: Not specified in the provided filing
• Footnotes/exhibits: Exhibit 24 — Power of Attorney included; no 10b5-1, tax-withholding, or other notes shown in the summary provided
• Filing timeliness: No late-filing flag shown; filing date is two days after the transaction

Context
A $0.00 per-share report usually reflects a compensatory grant (such as restricted stock or RSUs) rather than an open-market purchase. Such awards may be subject to vesting or transfer restrictions and therefore do not necessarily indicate immediate insider-buying sentiment. For full terms (vesting, restrictions, or value at grant), consult Cigna’s proxy statement, Form 8-Ks, or investor relations disclosures.